U.S. Oil and Gas Stock News

NYSE:VYX
NYSE:VYXSoftware

NCR Voyix (VYX) Is Up 8.2% After New Commerce Deals And Narrower Losses Has The Bull Case Changed?

NCR Voyix reported first-quarter 2026 results showing revenue of US$606 million and a reduced net loss of US$5 million, alongside continued share repurchases and updated full-year revenue guidance of US$2.19 billion to US$2.30 billion. Recent contract wins and expanded agreements with Stater Bros. Markets, Pei Wei and Gyro Hut highlight growing adoption of the Voyix Commerce Platform and the company’s shift toward software and services-led restaurant and retail technology. We’ll now examine...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

TMC The Metals Moves Toward Commercial Seafloor Production With Allseas Deal

TMC the metals (NasdaqGS:TMC) has signed a commercial agreement with Allseas to develop, commission and operate an offshore polymetallic nodule collection system. The system will operate in the Clarion Clipperton Zone and targets a production capacity of 3 million wet tonnes per year. Commissioning of what is expected to be the first large scale nodule recovery system is scheduled to begin in late 2027. TMC the metals is moving from a focus on permitting to building commercial...
NasdaqCM:EOSE
NasdaqCM:EOSEElectrical

Is Eos Energy Enterprises (EOSE) Pricing Reflect Recent Volatility And Mixed Valuation Signals

If you are wondering whether Eos Energy Enterprises is priced fairly or if the stock is offering value right now, this article explains what the current valuation signals indicate. The stock last closed at US$8.57, with returns of 34.3% over the past week, 52.5% over the past month, a decline of 33.9% year to date, and 35.4% over the past year. Taken together, these figures provide a mixed picture of recent performance and risk sentiment. Recent coverage of Eos Energy Enterprises has focused...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Slump

For investors wondering whether Enovis stock is starting to look like value or just looks cheap for a reason, this article walks through the key numbers so you can judge the price for yourself. After a recent 6.2% gain over the past week and a 1.5% rise over the past month, the stock still sits lower for the year to date, with a decline of 6.5%, and is down 32.2% over the past year, 56.7% over three years, and 67.3% over five years. Recent coverage has focused on how Enovis fits within the...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics Phase 3 Lung Data Could Reshape Pulmonary Franchise Outlook

United Therapeutics (NasdaqGS:UTHR) plans to present new phase 3 clinical data for Tyvaso (inhaled treprostinil for idiopathic pulmonary fibrosis) and ralinepag (for pulmonary arterial hypertension) at the upcoming American Thoracic Society International Conference. The company will also share additional research across multiple lung diseases, highlighting a broad set of respiratory-focused findings at the meeting. United Therapeutics focuses on therapies for serious pulmonary and...
NYSE:ABR
NYSE:ABRMortgage REITs

Arbor Realty Trust Resets Dividend As Asset Cleanup And 2027 Outlook Loom

Arbor Realty Trust (NYSE:ABR) has reset its quarterly dividend as part of a broader push to reduce nonperforming assets and real estate owned. Management is emphasizing faster resolution of troubled loans and a lower REO balance, alongside a growing origination pipeline. The company has highlighted plans that target improved asset quality and earnings in late 2026 and 2027. For income focused investors watching NYSE:ABR, the dividend reset comes after a tough stretch for the stock, with...
NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

Is It Too Late To Consider Marvell Technology (MRVL) After Its 165% One-Year Rally?

If you are wondering whether Marvell Technology at US$170.84 is priced for perfection or still offers value, the next sections will help you frame that question clearly. The stock has delivered returns of 4.4% over the past week, 33.0% over the last month, 91.1% year to date and 165.6% over the last year, with 3-year and 5-year returns of 310.2% and 306.9% respectively. Recent coverage has focused on Marvell's positioning within the semiconductor sector and how investors are reacting to its...
NasdaqGM:AGNT
NasdaqGM:AGNTReal Estate

AGNT Rebrands eXp With NextHome Acquisition And Multi Model Upside

eXp World Holdings, now trading under the ticker NasdaqGM:AGNT, has acquired franchise based brokerage NextHome. The company is shifting to a multi model real estate platform that offers both cloud brokerage and franchise options for agents and brokers. The new structure brings multiple brands under one global umbrella, with the AGNT ticker reflecting the broader platform focus. For real estate investors, NasdaqGM:AGNT now represents more than a pure cloud brokerage business. The...
NYSE:PHIN
NYSE:PHINAuto Components

PHINIA (PHIN) Is Up 8.1% After Debuting Hydrogen Van And Boosting Capital Returns - Has The Bull Case Changed?

In early May 2026, PHINIA Inc. showcased its first homologated hydrogen internal combustion engine light commercial vehicle at ACT Expo in Las Vegas, highlighting lower-carbon technology developed with Aramco that meets Euro 7 standards and targets very large reductions in tailpipe CO2 emissions versus diesel. The company coupled this technology milestone with a solid first-quarter earnings report, higher year-on-year sales and net income, continued 2026 guidance, and completion of a...
NasdaqGS:HEPS
NasdaqGS:HEPSMultiline Retail

A Look At Hepsiburada (HEPS) Valuation After Growth-Focused Earnings And Wider Net Loss

D-Market Elektronik Hizmetler ve Ticaret (HEPS) is back on investors’ radar after reporting first quarter 2026 results, with higher sales and gross merchandise value alongside a wider net loss driven by growth investments. See our latest analysis for D-Market Elektronik Hizmetler ve Ticaret. The earnings release appears to have cooled very short term sentiment, with the share price down 2.48% over the last day and 1.43% over the week. However, a 7.42% year to date share price return contrasts...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Assessing Bruker (BRKR) Valuation After A Recent Share Price Rebound

What Bruker’s recent performance means for investors Bruker (BRKR) has drawn attention after a mixed stretch for the stock, with a gain of about 19% over the past week and an increase of roughly 15% over the past month. See our latest analysis for Bruker. That recent burst of momentum, with an 18.9% 7 day share price return and a 15.1% 30 day share price return to US$43.27, contrasts with a softer year to date share price return and a 3 year total shareholder return that has been weak. As a...
NYSE:WLK
NYSE:WLKChemicals

Westlake (WLK) Valuation Check As Shares Rebound After Recent Pullback

Why Westlake Stock Is Drawing Attention Now Westlake (WLK) is back on investors’ radar after recent share price swings, with the stock up about 4% over the past day but down roughly 18% over the past month. See our latest analysis for Westlake. The recent 1-day share price return of 3.95% comes after a tougher stretch, with the 30-day share price return down 17.58% even as the year-to-date share price return is 31.57% and the 1-year total shareholder return is 16.98%. This points to fading...
NYSE:IDT
NYSE:IDTTelecom

Assessing IDT (IDT) Valuation After Strong April NRSInsights Same Store Sales Data

NRSInsights data on April same-store sales and transaction values has put a spotlight on IDT (IDT), as investors weigh how this retail activity feeds into the company’s broader communications and fintech operations. See our latest analysis for IDT. At a share price of $52.16, IDT has a 30 day share price return of 5.01% and a 90 day share price return of 6.38%, while the 1 year total shareholder return is down 9.36% and the 5 year total shareholder return is up 103.87%. This indicates that...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Assessing Oruka Therapeutics (ORKA) Valuation After Equity Raise Collaboration Deal And Trial Updates

Oruka Therapeutics (ORKA) stock is drawing attention after a recently completed $700 million common stock offering raised dilution concerns and coincided with volatility around its Halozyme Hypercon collaboration and interim clinical trial updates. See our latest analysis for Oruka Therapeutics. At a latest share price of US$65.68, Oruka’s recent common stock offering, Halozyme Hypercon agreement and interim trial readouts have gone hand in hand with sharp swings, including a 99.76% 3 month...
NasdaqGS:VECO
NasdaqGS:VECOSemiconductor

Assessing Veeco Instruments (VECO) Valuation After New US$250 Million Indium Phosphide Equipment Orders

Why Veeco’s new Indium Phosphide orders matter for investors Veeco Instruments (VECO) has drawn fresh attention after announcing more than US$250 million in new equipment orders tied to Indium Phosphide laser production for high speed optical transceivers in hyperscale data centers. For you as an investor, the interest here is less about a single headline number and more about what it signals: that Veeco’s tools sit directly in the supply chain for the shift from copper to optical...
NYSE:HESM
NYSE:HESMOil and Gas

Assessing Hess Midstream (HESM) Valuation After Strong Q1 2026 Results And Reaffirmed Guidance

Hess Midstream (HESM) reported first quarter 2026 results that showed higher revenue and net income versus the prior year, while also reaffirming full year earnings and operating guidance, a combination many income focused investors watch closely. See our latest analysis for Hess Midstream. Hess Midstream’s recent earnings announcement comes after a steady share price move, with the stock up 13.10% on a year to date share price basis and a 5 year total shareholder return of 140.87%. This...
NYSE:D
NYSE:DIntegrated Utilities

How Investors Are Reacting To Dominion Energy (D) Earnings Beat, Dividend Payout And New Debt Program

Dominion Energy’s recent quarterly update showed first-quarter 2026 sales rising to US$5,019 million while net income eased to US$621 million, alongside a confirmed quarterly dividend of US$0.6675 per share and a new US$3.00 billion shelf registration for floating rate demand notes with a dividend reinvestment plan. The company’s stronger-than-expected profit and revenue, reaffirmed earnings outlook, and rejection of shareholder proposals on governance and ESG-linked pay together highlight...
NYSE:GWW
NYSE:GWWTrade Distributors

W.W. Grainger (GWW) Is Up 7.4% After Raising 2026 Guidance And Boosting Dividend - What's Changed

In early May 2026, W.W. Grainger reported first-quarter 2026 results showing higher sales of US$4.74 billion and increased net income of US$555 million year over year, raised its full-year 2026 net sales and EPS guidance, and filed a new shelf registration for debt securities. Alongside these results, the company also announced a higher quarterly dividend of US$2.49 per share, extending its multidecade pattern of annual dividend increases and underlining management’s confidence in cash...
NYSE:EAT
NYSE:EATHospitality

A Look At Brinker International (EAT) Valuation After Recent Share Price Weakness

Brinker International (EAT) has drawn investor attention after a period of mixed share performance, including a decline of about 10% over the past month and roughly 14% over the past 3 months. See our latest analysis for Brinker International. Zooming out, the recent 10% 1 month share price decline and 14.4% 3 month share price decline contrast sharply with a 3 year total shareholder return of about 266%. This suggests momentum has cooled after a very strong multi year run. If you are...
NasdaqGS:PNTG
NasdaqGS:PNTGHealthcare

Pennant Group (PNTG) Is Up 9.7% After Q1 2026 Beat And Senior Living Expansion - Has The Bull Case Changed?

The Pennant Group, Inc. has already reported first-quarter 2026 results, with sales rising to US$285.36 million and net income to US$8.52 million, while also assuming operations of three senior living communities across Arizona and Wisconsin totaling 194 units. Together, the stronger earnings and continued expansion of Pennant’s senior living footprint highlight how the company is actively scaling its post-acute care and housing platform. Next, we’ll examine how Pennant’s stronger Q1...
NYSE:LXU
NYSE:LXUChemicals

What LSB Industries (LXU)'s Profit Rebound and Expansion Plans Mean For Shareholders

In late April 2026, LSB Industries, Inc. reported first-quarter sales of US$169.49 million and net income of US$19.69 million, reversing a loss a year earlier. Alongside this earnings improvement, management highlighted active review of debottlenecking projects and potential acquisitions or partnerships to expand fertilizer and industrial production capacity and gain scale. With earnings swinging to profit and management evaluating capacity-expanding investments, we’ll now examine how this...
NYSE:ABG
NYSE:ABGSpecialty Retail

Asbury Automotive Group (ABG) Valuation Check As Q1 Profit Gains And Buybacks Draw Fresh Attention

Why Asbury Automotive Group (ABG) Is In Focus After Q1 Asbury Automotive Group (ABG) is drawing fresh attention after first quarter results showed revenue of US$4,113 million, net income of US$187.8 million and diluted EPS of US$9.87, alongside continued share repurchases. Between January and March, the company bought back 678,000 shares for US$147 million, completing a broader repurchase of 2,187,090 shares totaling US$477.27 million under its existing program. See our latest analysis for...
NYSE:NGVT
NYSE:NGVTChemicals

Should Ingevity’s Divestiture-Driven Earnings and ESOP Shelf Filing Prompt Strategic Reassessment From NGVT Investors?

Ingevity Corporation recently reported past first-quarter 2026 results showing sales of US$258 million, net income of US$59.8 million, and earnings lifted by gains from divesting its Industrial Specialties and Road Markings product lines. The company also filed a US$45.16 million shelf registration for 580,000 common shares tied to its ESOP, highlighting ongoing capital management alongside a pivot toward higher-margin core businesses. Against this backdrop, we will now examine how the...
NYSE:U
NYSE:USoftware

Unity Software (U) Valuation Check After Q1 Beat Guidance Hike And AI Realignment

Unity Software (U) has become a focus for investors after first quarter results combined higher revenue, wider adjusted EBITDA margins, and large impairment driven GAAP losses tied to the ironSource and Supersonic restructuring. See our latest analysis for Unity Software. Unity's share price return is down 39.28% year to date despite a 24.28% 1 month gain and earnings news that combined revenue beats, higher adjusted margins, and large impairment driven losses. As a result, recent momentum...